Airborne, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Airborne, Inc. - overview

Location

Minneapolis, MN, US

Primary Industry

Food

About

Airborne, Inc. specializes in the development and marketing of health supplements aimed at enhancing immune system support, particularly during cold and flu seasons, with a focus on convenience and effectiveness for consumers. Airborne, Inc. is a health supplement company based in Minneapolis, US.


The company provides immune support products, undergoing a significant change when Schiff Nutrition acquired it for USD 150 mn in March 2012. The company was founded by Emmanuel Trenche, Hugo Tabares, Marvin Jacobs, and Rina Desai, while Arno Mourik currently serves as CEO. Airborne offers a variety of immune support supplements under its brand, including gummies, effervescents, and chewables designed for both adults and children. These products are formulated to support immune health, targeting health-conscious consumers, especially families.


Airborne's products, marketed in the US and select international markets, leverage scientifically-backed formulations to meet the growing demand for effective dietary supplements. In the most recent fiscal year of 2011, Airborne generated a revenue of USD 70. 00 mn through retail and direct-to-consumer sales channels, focusing on partnerships with major retailers and e-commerce platforms. The company's revenue model is supported by consumer loyalty programs like Schiff Rewards, enhancing repeat purchases and fostering strong customer relationships.


Airborne plans to utilize recent funding from the acquisition to invest in new product development and expand its market reach. There are upcoming launches of innovative immune support products targeting health-conscious consumers, planned for rollout within the next year. Additionally, the company is exploring expansion into new geographic regions, aiming to enter emerging markets and increase its international presence.


Current Investors

TPG Biotech, Schiff Nutrition

Primary Industry

Food

Sub Industries

Health Foods & Nutritional Supplements

Website

www.airbornehealth.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Airborne, Inc. - financials

Fiscal Year EndedJan 01, 2011
Revenue (USD)-
% Revenue Growth (YoY)-
EBITDA (USD)-
Operating Income (USD)-
Operating Margin-
% EBITDA Margin-
NET Income (USD)-
% Net Margin-

Airborne, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedAirborne, Inc.-
BuyoutCompletedAirborne, Inc.-

Displaying 1 - 2 of 2

Airborne, Inc. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.